Low-Dose Interleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older With Acute Myeloid Leukemia in First Complete Remission: Cancer and Leukemia Group B Study 9720
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 26 (30) 4934-4939
Year:
2008
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
Book Volume:
Parents:
706   2350  
Children:
None
Program:
OGC
Primary Committee:
Leukemia
Sec. Committees:
   
Pharmas:
 
Grants:
CA33601, CA02599, CA47577, CA32291, CA41287, CA03927, U10 CA033601, CA35279, CA77658, CA31983, CA31946  
Corr. Author:
 
Authors:
                           
Primary Study
Secondary Studies:
CALGB-8461, CALGB-9720, CALGB-9760
Phases:
, 3, N/A
Keywords:
Leukemia and Bone Marrow Transplantation